Act Advisors, Llc. Eli Lilly & CO Transaction History
Act Advisors, Llc.
- $181 Million
- Q4 2024
A detailed history of Act Advisors, Llc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Act Advisors, Llc. holds 318 shares of LLY stock, worth $255,697. This represents 0.14% of its overall portfolio holdings.
Number of Shares
318
Previous 278
14.39%
Holding current value
$255,697
Previous $246,000
0.41%
% of portfolio
0.14%
Previous 0.12%
Shares
3 transactions
Others Institutions Holding LLY
# of Institutions
4,054Shares Held
737MCall Options Held
8.27MPut Options Held
10.5M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$77.9 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.8MShares$59.3 Billion1.2% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$53 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$41.3 Billion29.2% of portfolio
-
State Street Corp Boston, MA33.9MShares$27.2 Billion1.24% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $764B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...